The epidemiology and risk factors of delayed diagnosis in newly reported HIV/AIDS cases in Xuhui District， Shanghai， 2018‒2022
Journal Title: Shanghai Journal of Preventive Medicine - Year 2024, Vol 36, Issue 5
Abstract
Objective To investigate the trends and significant determinants of delayed HIV diagnosis （DHD） among newly reported HIV/AIDS cases in Xuhui District， Shanghai between 2018 and 2022.Methods In the newly reported HIV/AIDS cases， patients died within one year without accident， HIV/AIDS cases with CD4 cell count <200 cells·μL-1， and AIDS cases with a CD4 cell count between 200 to 499 cells·μL-1 were defined as delayed diagnosis. Univariate and multivariate logistic analysis were employed to explore the influencing factors of DHD.Results Among the 862 newly reported HIV/AIDS cases， The DHD rate was 39.79% without statistically significant difference by year（χ2=4.508， P=0.342）. Patients with CD4 cell count <200 cells·μL-1 contributed the largest proportion of DHD. During 2018‒2022， the DHD rate declined among HIV/AIDS patients who were younger than 35 years old or 45‒65 years old， never married， original diagnosis from tertiary specialized hospitals. Patients who were 65 years or older， married or divorced， with heterosexual transmitted HIV/AIDS， and original diagnosis from other types of testing and tertiary metropolitan hospital， had sustainably higher DHD rates. The number of HIV screening and diagnosed from voluntary counseling and testing （VCT） decreased during the COVID-19 epidemic， while the DHD rate increased sharply. Multivariate logistic regression analysis suggested the DHD rates were higher among older age， other types of testing（OR=3.805， 95%CI： 2.260‒6.406）and pre-operative testing（OR=2.411， 95%CI： 1.424‒4.081）. Patients who received CD4 test in 15 days had a higher DHD rate compared to the cases received CD4 test exceeding 90 days （OR=0.336， 95%CI： 0.216‒0.522）.Conclusion There is no significant decrease of delayed HIV diagnosis rate in Xuhui District in recent years， and the number of HIV tests has decreased in 2022. Monitoring of newly reported HIV/AIDS should be conducted continuously. Expansion of HIV antibody screening should be conducted in non-infectious departments and inpatient departments in healthcare institutions， particularly metropolitan hospitals. Assistance should be provided to clinicians and elderly patients for improving their ability to recognize and perceive the risk of HIV/AIDS， in order to enhance early diagnosis and subsequent treatment.
Authors and Affiliations
ZHANG Boshu,ZHU Kaijin,ZHANG Jing,XU Ning,HUANG Wenyuan,CAI Xiaofeng,YANG Meixia,
Keywords
Related Articles
- EP ID EP742045
- DOI -
- Views 62
- Downloads 0
Analysis of influencing factors of post-vaccination serologic testing in children exposed to hepatitis B virus in Tongzhou District， Beijing from 2020 to 2022
Objective To explore the importance of post-vaccination serological testing （PVST） for children exposed to hepatitis B virus （HBV）， and analyze the factors affecting the progress of PVST.Methods The study focused on...
Comparative analysis of Aedes albopictus surveillance index in Yangpu District, Shanghai
Objective To analyze the interannual fluctuation， seasonal fluctuation， habitat distribution and the correlation of the 3 monitoring indicators of Aedes albopictus in Yangpu District of Shanghai from 2017 to 2021， and...
Design and baseline characteristics of a population-based birth cohort in Shanghai
Objective To introduce the basic design， development plan and objectives of a population-based birth cohort in Shanghai， and further present the main data and baseline characteristics of enrolled participants in the co...
Changes in HIV prevalence and intervention service utilization among MSM under sentinel monitoring in Taizhou of Zhejiang Province
ObjectiveTo analyze the changes in HIVï¼ syphilis and hepatitis C prevalence among men who have sex with men ï¼MSMï¼ in Taizhou Cityï¼ Zhejiang Province from 2017 to 2022ï¼ and the utilization of HIV intervention se...
Serological surveillance of human brucellosis in Ganzhou Cityï¼ Jiangxi Province from 2018 to 2021
ObjectiveTo describe the serological surveillance results of human brucellosis in Ganzhou Cityï¼ Jiangxi Province from 2018 to 2021ï¼ characterize the epidemic and current situation of brucellosisï¼ and to provide sci...